Literature DB >> 22588987

Correlates of motivation to change in pathological gamblers completing cognitive-behavioral group therapy.

Mónica Gómez-Peña1, Eva Penelo, Roser Granero, Fernando Fernández-Aranda, Eva Alvarez-Moya, Juan José Santamaría, Laura Moragas, Maria Neus Aymamí, Katarina Gunnard, José M Menchón, Susana Jimenez-Murcia.   

Abstract

OBJECTIVES: The present study analyzes the association between the motivation to change and the cognitive-behavioral group intervention, in terms of dropouts and relapses, in a sample of male pathological gamblers. The specific objectives were as follows: (a) to estimate the predictive value of baseline University of Rhode Island Change Assessment scale (URICA) scores (i.e., at the start of the study) as regards the risk of relapse and dropout during treatment and (b) to assess the incremental predictive ability of URICA scores, as regards the mean change produced in the clinical status of patients between the start and finish of treatment.
METHOD: The relationship between the URICA and the response to treatment was analyzed by means of a pre-post design applied to a sample of 191 patients who were consecutively receiving cognitive-behavioral group therapy. The statistical analysis included logistic regression models and hierarchical multiple linear regression models.
RESULTS: The discriminative ability of the models including the four URICA scores regarding the likelihood of relapse and dropout was acceptable (area under the receiver operating haracteristic curve: .73 and .71, respectively). No significant predictive ability was found as regards the differences between baseline and posttreatment scores (changes in R(2) below 5% in the multiple regression models).
CONCLUSIONS: The availability of useful measures of motivation to change would enable treatment outcomes to be optimized through the application of specific therapeutic interventions.
© 2012 Wiley Periodicals, Inc.

Entities:  

Keywords:  URICA; cognitive-behavioral therapy; motivation to change; pathological gambling; transtheoretical model of change

Mesh:

Year:  2012        PMID: 22588987     DOI: 10.1002/jclp.21867

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  4 in total

1.  Does Confinement Affect Treatment Dropout Rates in Patients With Gambling Disorder? A Nine-Month Observational Study.

Authors:  Isabel Baenas; Mikel Etxandi; Ester Codina; Roser Granero; Fernando Fernández-Aranda; Mónica Gómez-Peña; Laura Moragas; Sandra Rivas; Marc N Potenza; Anders Håkansson; Amparo Del Pino-Gutiérrez; Bernat Mora-Maltas; Eduardo Valenciano-Mendoza; José M Menchón; Susana Jiménez-Murcia
Journal:  Front Psychol       Date:  2021-12-14

2.  Treatment Outcome in Male Gambling Disorder Patients Associated with Alcohol Use.

Authors:  Susana Jiménez-Murcia; Amparo Del Pino-Gutiérrez; Fernando Fernández-Aranda; Roser Granero; Anders Hakänsson; Salomé Tárrega; Ana Valdepérez; Neus Aymamí; Mónica Gómez-Peña; Laura Moragas; Marta Baño; Anne Sauvaget; Maria Romeu; Trevor Steward; José M Menchón
Journal:  Front Psychol       Date:  2016-03-31

3.  A Serious Videogame as an Additional Therapy Tool for Training Emotional Regulation and Impulsivity Control in Severe Gambling Disorder.

Authors:  Salomé Tárrega; Laia Castro-Carreras; Fernando Fernández-Aranda; Roser Granero; Cristina Giner-Bartolomé; Neus Aymamí; Mónica Gómez-Peña; Juan J Santamaría; Laura Forcano; Trevor Steward; José M Menchón; Susana Jiménez-Murcia
Journal:  Front Psychol       Date:  2015-11-12

4.  Response trajectories of gambling severity after cognitive behavioral therapy in young-adult pathological gamblers.

Authors:  Roser Granero; Susana Valero-Solis; Fernando Fernández-Aranda; Mónica Gómez-Peña; Laura Moragas; Teresa Mena-Moreno; Amparo Del Pino-Gutierrez; Ester Codina; Virginia Martín-Romera; Gemma Casalé; Zaida Agüera; Isabel Baenas-Soto; Eduardo Valenciano-Mendoza; Bernat Mora-Maltas; Isabel Sánchez; María Lozano-Madrid; José M Menchón; Susana Jiménez Murcia
Journal:  J Behav Addict       Date:  2020-04-01       Impact factor: 6.756

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.